טיפול משולב עם מעכב mek, מעכב pd-1 וטקסאן
- 专利权人:
- GENENTECH INC.
- 发明人:
- 申请号：
- IL26566819
- 公开号：
- IL265668D0
- 申请日:
- 2019.03.27
- 申请国别(地区):
- IL
- 年份:
- 2019
- 代理人:
- 摘要：
- A combination therapy comprising a MEK inhibitor, a PD-1 or PD-L1 inhibitor, and a taxane is provided for the treatment of cancer, such as triple negative breast cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY WITH A MEK INHIBITOR, A PD-1 AXIS INHIBITOR, AND A TAXANE
- Combination therapy for cancers with BRAF mutation
- Combination therapy using MEK inhibitor, PD-1 axis inhibitor, and taxane
- СПОСОБЫ ЛЕЧЕНИЯ РАКА С ИСПОЛЬЗОВАНИЕМ АНТАГОНИСТОВ, СВЯЗЫВАЮЩИХСЯ С ОСЬЮ PD-1, И ИНГИБИТОРОВ MEK
- COMPOSITIONS AND METHODS FOR MEK INHIBITOR COMBINATION THERAPY IN THE TREATMENT OF CANCER
